For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures
Author
Abstract
Suggested Citation
DOI: 10.1371/journal.pone.0083646
Download full text from publisher
References listed on IDEAS
- Wenjin Yin & Yiwei Jiang & Zhenzhou Shen & Zhimin Shao & Jinsong Lu, 2011. "Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials," PLOS ONE, Public Library of Science, vol. 6(6), pages 1-9, June.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Stefania Gori & Alessandro Inno & Elena Fiorio & Jennifer Foglietta & Antonella Ferro & Marcella Gulisano & Graziella Pinotti & Marta Gubiotti & Maria Giovanna Cavazzini & Monica Turazza & Simona Dura, 2015. "The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-14, September.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Caroline S Clarke & Rachael M Hunter & Ian Shemilt & Victoria Serra-Sastre, 2017. "Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective," PLOS ONE, Public Library of Science, vol. 12(3), pages 1-19, March.
- Jeroen J. van den Broek & Nicolien T. van Ravesteyn & Eveline A. Heijnsdijk & Harry J. de Koning, 2018. "Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia," Medical Decision Making, , vol. 38(1_suppl), pages 54-65, April.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0083646. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.